Ditchcarbon
  • Customers
  1. Organizations
  2. Shattuck Labs, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Shattuck Labs, Inc.

Company website

Shattuck Labs, Inc., headquartered in the United States, is a pioneering biotechnology company focused on advancing the field of immunotherapy. Founded in 2016, Shattuck Labs has quickly established itself as a leader in the development of innovative therapies that harness the power of the immune system to combat cancer and other diseases. The company is renowned for its proprietary platforms, including the unique "Dual-Affinity Re-Targeting" (DART) technology, which enables the creation of bispecific therapeutics that can engage multiple targets simultaneously. This innovative approach sets Shattuck Labs apart in the competitive landscape of biopharmaceuticals. With a strong emphasis on research and development, Shattuck Labs has achieved significant milestones, including strategic partnerships and advancing multiple candidates into clinical trials, solidifying its position as a key player in the immuno-oncology sector.

DitchCarbon Score

How does Shattuck Labs, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Shattuck Labs, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Shattuck Labs, Inc.'s reported carbon emissions

Shattuck Labs, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Shattuck Labs may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, the company's climate commitments remain unclear, and it does not inherit any emissions data from a parent or related organisation.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shattuck Labs, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Shattuck Labs, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shattuck Labs, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bio-Thera Solutions, Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Exelixis, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Pyxis Oncology, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

ImmuneOncia Therapeutics, Inc.

KR
Updated 10 days ago

OSE Immunotherapeutics SA

FR
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy